echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > M & a market cooling down medical health leads M & a market for the first time

    M & a market cooling down medical health leads M & a market for the first time

    • Last Update: 2013-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2013-08-02 source: statistics from China Venture Investment Group, China economic times, show that in July this year, there was no large-scale M & a transaction in China's M & a market, and the overall activity decreased In July, the transaction size of China's M & a market was US $2.004 billion, down 76% on a month on month basis, and the number of completed transactions was 98, down 30% on a month on month basis From the perspective of transaction scale distribution, the medical health, real estate and financial industries ranked first, with the transaction scale of US $565 million, US $311 million and US $305 million respectively, accounting for 28%, 16% and 15% of the total, and the cumulative proportion of the three industries reached 59% According to the statistics of China Venture Investment Group, in July 2013, China's M & a market announced the transaction scale of US $19.474 billion, down 50% month on month; the number of M & A transactions was 254, down 26% month on month On June 29, PetroChina announced that it planned to acquire 8.33% of Kashagan, Kazakhstan's largest oil field, from Kazakhstan national oil and gas company for 5 billion US dollars Driven by the deal, China's M & a market announced in June that the scale of the deal jumped to the second place this year, only lower than that of January driven by CNOOC's large-scale deal of 15.1 billion US dollars On June 11, CNPC announced that it would publicly issue domestic corporate bonds with a total amount of no more than 60 billion yuan in the mainland The raised funds are intended to be used for the company's medium and long-term fund demand, debt restructuring adjustment and replenishment of working capital It is expected that the issuance will also reserve and replenish funds for CNPC's frequent overseas acquisitions in recent years Judging from the major transaction cases announced in July, there are two cases in the Internet industry that attract more attention: on July 16, baidu announced that it planned to wholly acquire 100% of the equity of 91 wireless network Co., Ltd., a smart phone service platform that focuses on the development and expansion of wireless Internet business under netlong network This transaction also continued bat's PC business this year In addition, Chinanet group sold its portal website, Chinanet, to Guoguang global media Holding Co., Ltd for HK $90.8 million, which has been in a loss state, which is the main reason for the sale On July 28, CYTS plans to acquire 15% shares of Wuzhen tourism jointly held by haotiancapital I  limited and haotiancapital II  limited for us $67.5 million After the completion of the transaction, CYTS will increase its share of Wuzhen tourism to 66% Behind the deal, IDG capital withdrew On July 16, Shanda literature announced that it has obtained strategic investment from Xinhua new media The two sides will promote cooperation in the fields of digital reading, copyright development, information service, electronic newspaper and magazine distribution platform, and provide mutual support in data, technology and other aspects in the expansion of online media On July 10, Shanda literature announced that it was invested by Goldman Sachs and Temasek for $110 million On July 12, Shanda literature cancelled its IPO application because the previous IPO application documents had not been updated for more than one year Under the background of the cold capital market and the downturn of China equity market, Shanda literature has successively obtained strategic investment from enterprises with international capital and domestic state-owned capital background, which highlights its own competitive strength According to the actual completed merger and acquisition cases, in February this year, zhangqu technology announced to purchase 100% of the equity of mobile pioneer, a research and development company of Yeyou, for a consideration of 810 million yuan This acquisition is accompanied by quite strict gambling agreement Mobile pioneer shareholders promised that their net profits from 2013 to 2015 will be no less than 74.85 million yuan, 93.43 million yuan and 11237 million yuan respectively In case of failure, pioneer shareholders of China Mobile need to compensate the unfinished net profit and return the purchase amount according to the proportion of profit difference in 2013-2015 profit On July 3, the transaction was completed At the same time, there was another case of transaction failure in the M & a market and VC / PE market that attracted attention: Chengdu feiji announced on July 10 that the transaction was terminated because it did not reach an agreement with Tongjie technology on the relevant consideration payment and asset price of the corresponding equity Behind the transaction, a large number of VC / PE Institutions among the shareholders of Tongjie technology ask too much for exit, which is the main reason for the failure of the transaction According to cvsource statistics, there are many institutions behind Tongjie technology, such as China Science and technology investment promotion, Fuli investment, and Chuangdang The integration trend of the medical industry highlights that a case with large transaction scale in July came from the medical field On June 12, Mindray, a leading domestic manufacturer of high-tech medical equipment R & D, plans to acquire all the equity of zunare, an American ultrasound technology development enterprise, for us $105 million Mindray hopes to strengthen the company's R & D capability in high-end ultrasound and further expand the US market through this acquisition The transaction will be paid in cash and third-party borrowings On July 17, Mindray announced the completion of the transaction, and the M & A and integration in the field of domestic health care are ready to move In July, 16, 13 and 12 cases of finance, manufacturing and energy mining accounted for 16%, 13% and 12% of the total number of M & A cases From the perspective of transaction scale distribution, the medical health, real estate and financial industries rank first in transaction scale, with M & a scale of US $565 million, US $311 million and US $305 million, respectively, accounting for 28%, 16% and 15% of the transaction scale respectively At the same time, the industry distribution of M & A transactions in July has changed a lot compared with that in the past The dominant energy industry has plummeted in this month's M & A transactions, ranking in the middle of the month with only US $60.4 million, while the integration trend of medical health and real estate industry is prominent In addition to the above mentioned M & R outbound acquisition transactions, the medical health industry in China is 26.84 Billion yuan  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.